Mirati Therapeutics, Inc.: meeting of 13 Dec 2023

Votes reported on Form N-PX, item by item

350 Form N-PX filers reported votes at the Mirati Therapeutics, Inc. meeting of 13 Dec 2023. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

7 vote records from 7 filers. 2 of the 7 filers that marked the item either way voted against management.

71.4% for28.6% against28.6% against management7 filers100.0% for0.0% against0.0% against management7,242,388 reported shares

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

472 vote records from 335 filers. 229 of the 315 filers that marked the item either way voted against management. 20 filers reported this item without a management mark.

2 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided

25.1% for68.4% against6.6% other72.7% against management335 filers0.7% for99.3% against0.0% other99.3% against management3,827,449,562 reported shares

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

171 vote records from 93 filers. 1 of the 93 filers that marked the item either way voted against management.

98.9% for0.0% against1.1% other1.1% against management93 filers99.9% for0.0% against0.1% other0.1% against management12,701,202 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

229 vote records from 111 filers. 14 of the 111 filers that marked the item either way voted against management.

87.4% for11.7% against0.9% other12.6% against management111 filers77.0% for22.9% against0.1% other23.0% against management14,148,491 reported shares, counted once per item in this group

How the largest families voted

Family	2. Merger pay
Vanguard	For
BlackRock and iShares	Against *
Fidelity	Against *
Dimensional	Against *
State Street and SPDR	For
American Century	Against *
Franklin Templeton	Against *
Invesco	Against *
Equitable	Against *
Charles Schwab	Against *
Nuveen and TIAA	Against *
ProShares and ProFunds	Against *
John Hancock and Manulife	Against *
Morgan Stanley, Eaton Vance and Calvert	Against *
J.P. Morgan	Against *
Goldman Sachs	Against *
WisdomTree	Against *
PGIM and Prudential	Against *
Jackson National funds	Against *
Northern Trust and FlexShares	Against *
SEI	Against *
T. Rowe Price	Against *
Lincoln Financial	Against
Voya	Against *
First Trust	Against *
Nationwide	Against *
Victory Capital	Against *
Brighthouse Funds	Against *
Guggenheim and Rydex	Against *
Columbia Threadneedle	Against *
BNY Mellon	Against *
Principal	Against *
Pacific Life funds	Against *
Transamerica	Against *
Federated Hermes	Against *
AllianceBernstein	Against *
DWS	Against *
Allspring	Against *
Virtus	For
Macquarie and Delaware Funds	Against *
Janus Henderson	Against *
Neuberger Berman	Against *
Natixis and Loomis Sayles	Against *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Mirati Therapeutics, Inc. meeting?

350 Form N-PX filers reported votes at the meeting of 13 Dec 2023. On say-on-pay, 2 of 7 voted against management (28.6%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Mirati Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Mirati Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Mirati Therapeutics, Inc. with a meeting date within three days of 13 Dec 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.